IGC Pharma Financial Overview
IGC Pharma's market cap is currently €23.79M. The company's EPS TTM is €-0.017089971; its P/E ratio is ―; IGC Pharma is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is €-0.02. See an overview of income statement, balance sheet, and cash flow financials.
